The Europe Enteral Feeding Formulas Market is expected to witness market growth of 8.1% CAGR during the forecast period (2022-2028).
These nutrients include carbohydrates (40-60% of total energy demands), protein (14-20% of total energy needs), fat (15-30% of total energy needs), and fiber. For patients with an enteral feeding indication, a variety of parameters, including caloric density, osmolarity and osmolality, delivery channel, source and complexity of nutrients, and disease, are taken into account. The patient's daily calorie requirements are considered while determining the enteral feeding formula's caloric density. Less water is present in enteral diets with increased energy density.
The availability of vitamins and minerals varies depending on the individual demands of the patients and their ailment. Even though the formulation as a whole meets the values required by the Recommended Dietary Allowance, the caretakers and care providers should assess the indication of extra micronutrient supplementation (RDA).
The elderly population in Europe is steadily growing, which has also led to an increase in chronic diseases there. There are a variety of effects of the EU-27's aging population (those 85 years of age or older). Given that elderly individuals tend to use proportionately more social services than younger people, one of the primary areas of concern for the relevant authority is the cost of providing adequate health and long-term care.
Additionally, the number of elderly people with neurological disorders that impair swallowing, such as multiple sclerosis, stroke, and dementia, is rising. Therefore, the issue of nutrition insufficiency among these diagnosed populations is reduced by the availability of nutritional support in the form of oral nutrition supplements and enteral nutrition feeding tube support.
The Germany market is leading the Europe Enteral Feeding Formulas Market by Country in 2021; thereby, achieving a market value of $561.1 million by 2028. The UK market is expected to witness a CAGR of 7.2% during (2022 - 2028). Additionally, The France market is expected to witness a CAGR of 8.9% during (2022 - 2028).
Based on End User, the market is segmented into Hospitals, Long Term Care facilities, Nursing Homes, Assisted Living Facilities, and Home Care Agencies & Hospices. Based on Application, the market is segmented into Oncology, Neurological Disorders, Gastrointestinal Diseases, Diabetes, and Others. Based on Stage, the market is segmented into Adults and Pediatric. Based on Product, the market is segmented into Standard Formula, Disease specific, Diabetic Formula, Renal Formula, Hepatic Formula, Pulmonary Formula, Peptide-based Formula, Other Disease Specific Formula, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Danone S.A. (Sofina Group), Nestle S.A., Fresenius SE & Co. KGaA, B. Braun Melsungen AG, Otsuka Pharmaceutical Co., Ltd., Meiji Holdings Co., Ltd., Reckitt Benckiser Group PLC, Hormel Foods Corporation and Medline Industries, Inc.
These nutrients include carbohydrates (40-60% of total energy demands), protein (14-20% of total energy needs), fat (15-30% of total energy needs), and fiber. For patients with an enteral feeding indication, a variety of parameters, including caloric density, osmolarity and osmolality, delivery channel, source and complexity of nutrients, and disease, are taken into account. The patient's daily calorie requirements are considered while determining the enteral feeding formula's caloric density. Less water is present in enteral diets with increased energy density.
The availability of vitamins and minerals varies depending on the individual demands of the patients and their ailment. Even though the formulation as a whole meets the values required by the Recommended Dietary Allowance, the caretakers and care providers should assess the indication of extra micronutrient supplementation (RDA).
The elderly population in Europe is steadily growing, which has also led to an increase in chronic diseases there. There are a variety of effects of the EU-27's aging population (those 85 years of age or older). Given that elderly individuals tend to use proportionately more social services than younger people, one of the primary areas of concern for the relevant authority is the cost of providing adequate health and long-term care.
Additionally, the number of elderly people with neurological disorders that impair swallowing, such as multiple sclerosis, stroke, and dementia, is rising. Therefore, the issue of nutrition insufficiency among these diagnosed populations is reduced by the availability of nutritional support in the form of oral nutrition supplements and enteral nutrition feeding tube support.
The Germany market is leading the Europe Enteral Feeding Formulas Market by Country in 2021; thereby, achieving a market value of $561.1 million by 2028. The UK market is expected to witness a CAGR of 7.2% during (2022 - 2028). Additionally, The France market is expected to witness a CAGR of 8.9% during (2022 - 2028).
Based on End User, the market is segmented into Hospitals, Long Term Care facilities, Nursing Homes, Assisted Living Facilities, and Home Care Agencies & Hospices. Based on Application, the market is segmented into Oncology, Neurological Disorders, Gastrointestinal Diseases, Diabetes, and Others. Based on Stage, the market is segmented into Adults and Pediatric. Based on Product, the market is segmented into Standard Formula, Disease specific, Diabetic Formula, Renal Formula, Hepatic Formula, Pulmonary Formula, Peptide-based Formula, Other Disease Specific Formula, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Danone S.A. (Sofina Group), Nestle S.A., Fresenius SE & Co. KGaA, B. Braun Melsungen AG, Otsuka Pharmaceutical Co., Ltd., Meiji Holdings Co., Ltd., Reckitt Benckiser Group PLC, Hormel Foods Corporation and Medline Industries, Inc.
Scope of the Study
Market Segments Covered in the Report:
By End User- Hospitals
- Long Term Care facilities
- Nursing Homes
- Assisted Living Facilities
- Home Care Agencies & Hospices
- Oncology
- Neurological Disorders
- Gastrointestinal Diseases
- Diabetes
- Others
- Adults
- Pediatric
- Standard Formula
- Disease specific
- Diabetic Formula
- Renal Formula
- Hepatic Formula
- Pulmonary Formula
- Peptide-based Formula
- Other Disease Specific Formula
- Others
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Key Market Players
List of Companies Profiled in the Report:
- Abbott Laboratories
- Danone S.A. (Sofina Group)
- Nestle S.A.
- Fresenius SE & Co. KGaA
- B. Braun Melsungen AG
- Otsuka Pharmaceutical Co., Ltd.
- Meiji Holdings Co., Ltd.
- Reckitt Benckiser Group PLC
- Hormel Foods Corporation
- Medline Industries, Inc.
Unique Offerings from the Publisher
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 4. Europe Enteral Feeding Formulas Market by End User
Chapter 5. Europe Enteral Feeding Formulas Market by Application
Chapter 6. Europe Enteral Feeding Formulas Market by Stage
Chapter 7. Europe Enteral Feeding Formulas Market by Product
Chapter 8. Europe Enteral Feeding Formulas Market by Country
Chapter 9. Company Profiles
Companies Mentioned
- Abbott Laboratories
- Danone S.A. (Sofina Group)
- Nestle S.A.
- Fresenius SE & Co. KGaA
- B. Braun Melsungen AG
- Otsuka Pharmaceutical Co., Ltd.
- Meiji Holdings Co., Ltd.
- Reckitt Benckiser Group PLC
- Hormel Foods Corporation
- Medline Industries, Inc.
Methodology
LOADING...
